首页 | 本学科首页   官方微博 | 高级检索  
检索        

抗原NY-BR-1的HLA-A2限制性CTL表位的初步鉴定
引用本文:赵婷婷,吴玉章,林治华,周伟,贾正才,邹丽云.抗原NY-BR-1的HLA-A2限制性CTL表位的初步鉴定[J].中国免疫学杂志,2003,19(8):540-543.
作者姓名:赵婷婷  吴玉章  林治华  周伟  贾正才  邹丽云
作者单位:第三军医大学全军免疫研究所,重庆,400038
基金项目:本研究为国家自然科学基金资助项目(批准号:30200277)
摘    要:目的:鉴定乳腺癌分化肿瘤抗原NY-BR-1的HLA-A2限制性CTL表位。方法:采用量化基序法初步预测NYBR-1的HLA-A2限制性CTL表位;分子动力学方法进一步筛选量化基序法中评分最高的3个表位肽;HLA-A2亲合力鉴定预测的结果。结果:分子动力学和HLA-A2亲合力实验均证明,在量化基序法预测的3个候选CTL表位中,NY-BR-11043-1051与HLA-A2亲合力最佳。结论:NY-BR-11043-1051可能为乳腺癌分化抗原NY-BR-1的HLA-A2限制性CTL表位。

关 键 词:抗原NY-BR-1  HLA-A2限制性  CTL表位  鉴定  乳腺癌
文章编号:1000-484X(2003)08-0540-04

Identification a HLA-A2-restricted CTL epitope of breast cancer differentiation antigen NY-BR-1
ZHAO Ting-Ting,WU Yu-Zhang,LIN Zhi-Hua et al.Identification a HLA-A2-restricted CTL epitope of breast cancer differentiation antigen NY-BR-1[J].Chinese Journal of Immunology,2003,19(8):540-543.
Authors:ZHAO Ting-Ting  WU Yu-Zhang  LIN Zhi-Hua
Institution:ZHAO Ting-Ting,WU Yu-Zhang,LIN Zhi-Hua et al.Institute of Immunology PLA,Third Military Medical University,Chongqing 400038,China
Abstract:Objective:To identify HLA-A2-restricted CTL epitope of breast cancer differentiation antigen NY-BR-1.Methods:The HLA-A2-restricted CTL epitope of breast cancer differentiation antigen NY-BR-1 is predicted by combination quantitative motif method and the molecular dynamics.The three epitope were assayed their affinity to HLA-A2.Results:The affinity to HLA-A2 of NY-BR-1_ 1043-1051 is a best.Conclusion:NY-BR-1_ 1043-1051 is a HLA-A2 restricted epitope.
Keywords:Breast cancer  NY-BR-1  CTL epitope  Prediction  Identification
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号